Constipation Clinical Trial
Official title:
Home Versus Office Biofeedback Training for Dyssynergic Defecation
Test the Efficacy of Home Biofeedback Training: Currently, biofeedback requires a skilled
therapist and sophisticated equipment and is not widely available. The investigators designed
and tested a novel home biofeedback device and predict that home training will be as
effective as office biofeedback therapy. Our specific aims are to perform a randomized
controlled trial of 100 subjects with dyssynergic defecation to investigate:
(A) Whether a self-administered, home-biofeedback training program with a new portable device
is as effective as office-based biofeedback therapy in improving i) physiology- dyssynergia
(defecation index), and ability to expel simulated stool, and ii) symptomatology-
satisfaction with bowel function, number of complete spontaneous bowel movements, stool
consistency, straining and quality of life.
(B) Whether home-training is more cost-effective than office-based biofeedback training.
Study Protocol: Patients will be randomized to receive either office-based biofeedback
therapy or home-based biofeedback training, in addition to the standard treatment described
below.
Randomization procedures: The permuted blocks method will randomize patients for all study
aims; this ensures approximate balance among the two treatment arms, while making it unlikely
that investigators will predict the next treatment assignment. The study statistician will
prepare sequentially numbered sealed envelopes containing the treatment assignment. Thus the
next treatment assignment cannot be read without opening the envelope. If a patient is deemed
eligible, and agrees to participate, after signing the informed consent, the investigator
will open the next envelope to determine the treatment assigned to that patient.
Standard Treatment: The patient will be seen by one of the gastroenterologists and receive
instructions regarding their problem and advice on exercises, timed toilet training,
laxatives, diet and fluid intake. Written materials will be given to each patient and the
study coordinator will reinforce the information.
Timed-toilet training: This consists of educating the patient regarding the anatomy and
physiology of the pelvic floor and diaphragmatic breathing technique. They will be advised to
attempt a bowel movement twice a day, 30 minutes after meals and strain for five minutes and
push at a level of 5-7/10.
Laxatives: Patients will be asked to use 500 mg magnesium gluconate, 2-3 tablets/day or Milk
of Magnesia 1-3 tablespoons daily. If intolerant, they will be advised to use bisacodyl (1-2
daily) or sennokot (1-2 daily), but to titrate the dose. Patients will be asked to refrain
from using digital maneuvers and enemas. Rescue medications will include bisacodyl
suppositories (no BM for 48 hrs) or enema (no BM for 72 hours). If bowel movement is regular
i.e. soft stool >3/week, they will be asked to reduce the laxative dose by 1/3rd.
Diet: Based on a three-day prospective food diary, patients will get advice by the GCRC
dietician. The recommendations will include the advice to eat 5 servings of fruits and
vegetables per day, and 25 g dietary fiber from natural foods, and consume ~30% of calories
from fat. Three-day food records, obtained at baseline, and at 4, 8 and 12 weeks, will assess
dietary compliance. Subjects will get a diet report to reinforce adherence.
Office Biofeedback (Neuromuscular conditioning) Treatment- The aim of biofeedback will be to
establish a normal pattern of defecation and improve rectal sensation using visual/verbal
biofeedback technique. A monitor screen will provide visual feedback by showing changes in
pressure activity. First patients will be taught abdominal muscle coordination exercise to
improve the pushing effort during defecation. Here, patients are taught how to distend the
abdomen by inhaling slowly and then holding their breath for at least 15 seconds and to
practice this for 20 minutes, twice a day. Thereafter, patients will be asked to attend the
motility laboratory, biweekly for up to 6 training sessions. BT will be performed by a
3-sensor manometry probe. The clothed patient will be seated on a commode in front of a
monitor. The physician/nurse therapist will give verbal feedback by either complimenting the
patient for performing a correct maneuver or rectifying any errors. Each 60 minute treatment
session will comprise of the following maneuvers:
Recto-Anal Coordination This maneuver's goal is to produce a coordinated movement that
simultaneously increases the intra abdominal (intra rectal) pressure and relaxes the anal
sphincter. First, the patient is educated about their abnormal tracing: A normal pattern is
shown and they are encouraged to reproduce this. The patients' posture and breathing are
continuously monitored and corrected and verbal reinforcement provided. If a patient
consistently demonstrates normal rectoanal coordination, then they are asked to reproduce
this without feedback. Approximately 15 bearing down maneuvers are performed at 1 minute
intervals, some with and some without rectal balloon distention.
Simulated defecation: This is performed by placing a fecom (artificial stool) into the
rectum. The patient is asked to sit on a commode and expel the fecom. Their movements,
posture, and breathing techniques are corrected and feedback is provided. The therapist may
assist the patient's effort by applying gentle traction to the fecom, while reinforcing their
straining technique. The maneuver is repeated twice.
Assessment of Improvement: The number of training sessions will be customized for each
patient (maximum 6). Training will be discontinued if a patient demonstrates during two
consecutive training sessions, without feedback a) normal pattern of defecation in at least
50% of attempts, and b) at least 20% improvement in bowel satisfaction (VAS) (64). If these
goals are not achieved, patients will be considered treatment failures.
Home Biofeedback Treatment: After getting advice on standard treatment and breathing
exercises, patients will be taught how to use the home-trainer in a single lab session. Then
the investigators will place a reusable, dual sensor, probe into their rectum. The probe is
connected to a hand- held pressure monitor displaying the patient's response (Anatoner,
Protech, Hyderabad, India). Next, the clothed patient will be asked to sit on a commode, and
attempt 15 bearing down maneuvers. When the anal sphincter pressure decreases more lights go
on. If the patient cannot relax then fewer lights go on. Thus, the number of lighted lights
gives instant feedback about their performance. Patients will get a 20-minute tape recording
for home use. Patients will be asked to insert the probe at least twice daily and each time
practice at least 15 bearing down maneuvers; a daily log will be kept. At 4 and 8 weeks, they
will return for follow up. Based on their progress, new targets will be set by adjusting the
device's sensitivity. After 3-months, they will have a colonic transit, anorectal manometry
and fecom expulsion study. Progress will be monitored through bi-weekly phone calls.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 |